Additional file 2: of l-asparaginase-based regimens followed by allogeneic hematopoietic stem cell transplantation improve outcomes in aggressive natural killer cell leukemia
journal contributionposted on 18.04.2016 by Ki Jung, Su-Hee Cho, Seok Kim, Young Ko, Eun-Suk Kang, Won Kim
Any type of content formally published in an academic journal, usually following a peer-review process.
Summary of patients who underwent HSCT after SMILE or VIDL chemotherapy. One patient underwent autologous HSCT and 7 patients received allogeneic HSCT. No engraftment failure or treatment-related mortality occurred. But, 2 patients died from disease relapse (Autologous; 1, Allogeneic; 1). (DOCX 17 kb)